If you're not controlling your appetite, shame on you
However, relying on willpower alone after stopping the medication is challenging because the biological drive to regain weight is strong
The amycretin data looks stronger than the 19% weight loss at 36 weeks generated for Lillys next-generation drug retatrutide in phase 2 (phase 3 data is expected in 2026) and 20.4% cagrisema weight loss in a much longer 68-week trial
eye problems in people with diabetes
Ideal Candidate Profile: BMI 30 kg/m (obesity) or 27 kg/m (overweight) with weight-related health conditions Have genuinely tried lifestyle modifications including multiple structured diet attempts and regular exercise without sustained success No absolute contraindications (thyroid cancer history, MEN 2, current pregnancy, severe kidney disease) Willing to make concurrent meaningful diet improvements and increase physical activity Can commit financially and practically to minimum 12-month treatment course Understand medication is a tool enhancing lifestyle changes, not replacing them Have realistic expectations about typical weight loss outcomes over 6-12 months, not dramatic rapid transformation Willing to accept potential side effects and ongoing medical monitoring requirements Less Ideal or Inappropriate Candidate Profile: Looking for effortless quick fix without lifestyle commitment History of eating disorders requiring specialized treatment first (anorexia, bulimia, binge eating disorder) Significant mental health concerns not currently well-managed (severe depression, active suicidal ideation, psychosis) Medical contraindications requiring more intensive monitoring than telehealth provides Unable to financially sustain treatment for minimum 12-18 months needed for results Expecting guaranteed dramatic results or specific weight loss amounts Unwilling to accept gastrointestinal side effects or needle injections (though tablets available) Alternative Options Worth Considering First: Comprehensive Lifestyle Medicine Approach: Working with multidisciplinary team: registered dietitian, therapist, exercise physiologist, physician Addressing root causes: chronic stress, poor sleep, emotional eating triggers, trauma Building sustainable long-term habits without medication dependence Often more cost-effective long-term if successful without medication Can always add medication later if lifestyle-only approach insufficient Evidence-Based Behavioral Weight Loss Programs: Noom, Weight Watchers, or other structured programs ($20-80/month) Lower cost entry points testing commitment and readiness Develop essential skills needed for long-term maintenance regardless of medication use Provide accountability, community support, and behavior change education May identify that medication unnecessary if structured program sufficient Traditional Medical Weight Loss Clinics: In-person care providing better accountability and monitoring for some patients Comprehensive medical evaluation including extensive lab work and metabolic testing Access to full range of medication options beyond just GLP-1 (phentermine, naltrexone-bupropion, orlistat) Higher touch support during critical initiation periods and plateau troubleshooting May accept insurance coverage reducing out-of-pocket costs Bariatric Surgery Evaluation: For individuals with BMI 40 or 35 with serious weight-related comorbidities More dramatic and sustained weight loss for severe obesity (60-80% excess weight loss typical) One-time intervention versus ongoing medication expense Comprehensive insurance coverage more common for surgery than medications Addresses obesity through multiple mechanisms including anatomical restriction and metabolic changes Lifestyle and Personal Readiness Factors Do You Have Support Systems for Success
In STEP-1, only 7.0% of semaglutide participants discontinued due to gastrointestinal adverse events, compared with 3.1% on placebo [2]
